Literature DB >> 24556868

Alterations of global histone H3K9 and H3K27 methylation levels in bladder cancer.

Jörg Ellinger1, Anne Bachmann, Friederike Göke, Turang E Behbahani, Claudia Baumann, Lukas C Heukamp, Sebastian Rogenhofer, Stefan C Müller.   

Abstract

BACKGROUND: Epigenetic alterations, including histone modifications, play an important role during carcinogenesis. This study was designed to systematically investigate histone H3K9 and H3K27 methylation levels in bladder cancer (BCa) tissue.
METHODS: A tissue microarray with urothelial BCa (150 non-muscle-invasive BCa, NMIBC; 121 muscle-invasive BCa, MIBC; 31 metastatic BCa, MET) and normal urothelium (29, CTRL) specimen was used to determine the global levels of H3K9 and H3K27 mono-, di- and tri-methylation.
RESULTS: Global levels of H3K9 and H3K27 methylation were significantly higher in CTRL than in BCa, and levels in NMIBC were higher compared to MIBC. Histone methylation levels of MET resembled MIBC. We observed furthermore a correlation of histone methylation levels with pT stage (H3K9me1, H3K9me2, H3K9me3, H3K27me1, H3K27me3) and grade (H3K9me2, H3K9me3, H3K27me1) in NMIBC. H3K9me1, H3K9me3, H3K27me1 and H3K27me3 levels were also correlated with pT stage in MIBC. Histone modifications were not associated with recurrence-free or cancer-specific survival.
CONCLUSIONS: Global histone H3K9 and H3K27 methylation levels are altered in BCa.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24556868     DOI: 10.1159/000355467

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  13 in total

Review 1.  Role of Chromatin Modifying Complexes and Therapeutic Opportunities in Bladder Cancer.

Authors:  Khyati Meghani; Lauren Folgosa Cooley; Andrea Piunti; Joshua J Meeks
Journal:  Bladder Cancer       Date:  2022-06-03

2.  DNA Methylation of Telomere-Related Genes and Cancer Risk.

Authors:  Brian T Joyce; Yinan Zheng; Drew Nannini; Zhou Zhang; Lei Liu; Tao Gao; Masha Kocherginsky; Robert Murphy; Hushan Yang; Chad J Achenbach; Lewis R Roberts; Mirjam Hoxha; Jincheng Shen; Pantel Vokonas; Joel Schwartz; Andrea Baccarelli; Lifang Hou
Journal:  Cancer Prev Res (Phila)       Date:  2018-06-12

3.  Emerging role of linker histone variant H1x as a biomarker with prognostic value in astrocytic gliomas. A multivariate analysis including trimethylation of H3K9 and H4K20.

Authors:  Athanasia Sepsa; Georgia Levidou; Antonis Gargalionis; Christos Adamopoulos; Anastasia Spyropoulou; Georgia Dalagiorgou; Irene Thymara; Efstathios Boviatsis; Marios S Themistocleous; Kalliopi Petraki; George Vrettakos; Vassilis Samaras; Athanassios Zisakis; Efstratios Patsouris; Christina Piperi; Penelope Korkolopoulou
Journal:  PLoS One       Date:  2015-01-20       Impact factor: 3.240

4.  Histone trimethylation at H3K4, H3K9 and H4K20 correlates with patient survival and tumor recurrence in early-stage colon cancer.

Authors:  Anne Benard; Inès J Goossens-Beumer; Anneke Q van Hoesel; Wouter de Graaf; Hamed Horati; Hein Putter; Eliane C M Zeestraten; Cornelis J H van de Velde; Peter J K Kuppen
Journal:  BMC Cancer       Date:  2014-07-22       Impact factor: 4.430

5.  A single double-strand break system reveals repair dynamics and mechanisms in heterochromatin and euchromatin.

Authors:  Aniek Janssen; Gregory A Breuer; Eva K Brinkman; Annelot I van der Meulen; Sean V Borden; Bas van Steensel; Ranjit S Bindra; Jeannine R LaRocque; Gary H Karpen
Journal:  Genes Dev       Date:  2016-07-15       Impact factor: 11.361

Review 6.  Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer.

Authors:  Peter McAnena; James A L Brown; Michael J Kerin
Journal:  Cancers (Basel)       Date:  2017-01-08       Impact factor: 6.639

Review 7.  Genetic and Epigenetic Alterations in Bladder Cancer.

Authors:  Hong-Tao Li; Christopher E Duymich; Daniel J Weisenberger; Gangning Liang
Journal:  Int Neurourol J       Date:  2016-11-22       Impact factor: 2.835

8.  HiHiMap: single-cell quantitation of histones and histone posttranslational modifications across the cell cycle by high-throughput imaging.

Authors:  Linda Zane; Fleur Chapus; Gianluca Pegoraro; Tom Misteli
Journal:  Mol Biol Cell       Date:  2017-06-14       Impact factor: 4.138

Review 9.  Epigenetic therapy in urologic cancers: an update on clinical trials.

Authors:  Inês Faleiro; Ricardo Leão; Alexandra Binnie; Ramon Andrade de Mello; Ana-Teresa Maia; Pedro Castelo-Branco
Journal:  Oncotarget       Date:  2017-02-14

Review 10.  Mass spectrometry-based characterization of histones in clinical samples: applications, progress, and challenges.

Authors:  Roberta Noberini; Giulia Robusti; Tiziana Bonaldi
Journal:  FEBS J       Date:  2021-01-23       Impact factor: 5.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.